Radiogenic therapy: Novel approaches for enhancing tumor radiosensitivity

Technology in Cancer Research and Treatment

Volumn 4, Issue 4, 2005, Pages 343-361

  Robson, T ^a   Worthington, J ^b   McKeown, S R ^b   Hirst, D G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

And transcriptional targeting; Cancer; GDEPT; Gene therapy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; CYTOSINE DEAMINASE; EARLY GROWTH RESPONSE FACTOR 1; GANCICLOVIR; GENE PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 24; INTERLEUKIN 3; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANGANESE SUPEROXIDE DISMUTASE; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 7; NITRIC OXIDE SYNTHASE; PROSTATE SPECIFIC ANTIGEN; PROTEIN HSV TK; PROTEIN P16; PROTEIN P21; PROTEIN P53; PROTEIN TSLC1; SODIUM IODIDE SYMPORTER; THYMIDINE KINASE INHIBITOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANTIBODY DIRECTED ENZYME PRODRUG THERAPY; CANCER RADIOTHERAPY; DOSE CALCULATION; ENZYME THERAPY; GENE CORRECTION THERAPY; GENE DIRECTED ENZYME PRODRUG THERAPY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; HUMAN; HUMAN CELL; NONHUMAN; PROMOTER REGION; RADIATION DOSE; RADIOSENSITIVITY; REVIEW; TREATMENT PLANNING;

EID: 24144465724     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460500400404     Document Type: Review

References (217)

1. Wang, C. C. Radiation Therapy for Head and Neck Neoplasms, Wiley-Liss, New York (1997).
2. Hoskins, P. J., Price, P., Easton, D., Regan, J., Austin, D., and Palmer, S. A Prospective Randomised Trial of 4Gy or 8Gy Single Doses in the Treatment of Metastatic Bone Pain. Radiother Oncol 25, 74-78 (1992).
3. Fu, K. K., Pajak, T. F., Trotti, A., Jones, C. U., Spencer, S. A., Phillips, T. L., Garden, A. S., Ridge, J. A., Cooper, J. S., and Ang, K. K. A Radiation Therapy Oncology Group (RTOG) Phase III Randomized Study to Compare Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinomas: First Report of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 48, 7-16 (2000).
4. Overgaard, J., Sandhansen, H., Overgaard, M., Bastholt, L., Specht, L., and Evenson, J. Conventional Radiotherapy as Primary Treatment of Squamous Cell Carcinoma of the Head and Neck. A Randomised Multicentre Study of 5 Versus 6 Fractions Per Week - Report from the DAHANCA 7 Trial. Int. J. Radiat. Oncol. Biol. Phys. 39, 118 (1997).
5. Slevin, N. J., West, C. M., Wilson, G. D., and Hendry, J. H. The Potential Benefit from Individualised Radiotherapy Scheduling for Head and Neck Tumours on the Basis of Both Histological Grade and Kinetics. Radiother. Oncol. 51, 109-111 (1999).
6. Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., and Prosnitz, L. R. Hyperfractionated Irradiation With or Without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer. N. Engl. J. Med. 338, 1798-1804 (1998).
7. Green, J. A., Kirwan, J. M., Tierney, J. F., Symonds, P., Fresco, L., Collingwood, M., and Williams, C. J. Survival and Recurrence After Concomitant Chemotherapy and Radiotherapy for Cancer of the Uterine Cervix: A Systematic Review and Meta-analysis. Lancet 555, 781-786 (2001).
8. Ma, B. B., Bristow, R. G., Kim, J., and Siu, L. L. Combined-modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents. J. Clin. Oncol. 27, 2760-2776 (2003).
9. Tan, F. L. and Yin, J. Q. Application of RNAi to Cancer Research and Therapy. Front. Biosci. 10, 1946-1960 (2005).
10. Dachs, G. U., Tupper, J., and Tozer, G. M. From Bench to Bedside for Gene-directed Enzyme Prodrug Therapy of Cancer. Anticancer Drugs 16, 349-359 (2005).
11. Fulda, S. and Debatin, K. M. Targeting Apoptosis Pathways in Cancer Therapy. Curr. Cancer. Drug Targets 4, 569-576 (2004).
12. Shinohara, E. T., Lu, B., and Hallahan, D. E. The Use of Gene Therapy in Cancer Research and Treatment. Technol. Cancer. Res. Treat. 3, 479-490 (2004).
13. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent Apoptosis Modulates the Cytotoxicity of Anticancer Agents. Cell 74, 957-967 (1993).
14. Haupt, S. and Haupt, Y. Improving Cancer Therapy Through p53 Management. Cell. Cycle 3, 912-916 (2004).
15. Haupt, S. and Haupt, Y. Manipulation of the Tumor Suppressor p53 for Potentiating Cancer Therapy. Semin. Cancer Biol. 14, 244-252 (2004).
16. Lebedeva, I. V., Su, Z. Z., Sarkar, D., and Fisher, P. B. Restoring Apoptosis as a Strategy for Cancer Gene Therapy. Focus on p53 and mda-7. Semin. Cancer Biol. 13, 169-178 (2003).
17. M. Edelstein. Gene Therapy Clinical Trials Worldwide; Provided by Journal of Gene Medicine, http://82.182.180.141/trials/index.html (2005).
18. Spitz, F. R., Nguyen, D., Skibber, J. M., Meyn, R. E., Cristiano, R. J., and Roth, J. A. Adenoviral-mediated Wild-type p53 Gene Expression Sensitizes Colorectal Cancer Cells to Ionizing Radiation. Clin. Cancer Res. 2, 1665-1671 (1996).
19. Gallardo, D., Drazan, K. E., and McBride, W. H. Adenovirus-based Transfer of Wild-type p53 Gene Increases Ovarian Tumor Radiosensitivity. Cancer Res. 56, 4891-4893 (1996).
20. Li, J. H., Lax, S.A., Kim, J., Klamut, H., and Liu, F. F. The Effects of Combining Ionizing Radiation and Adenoviral p53 Therapy in Nasopharyngeal Carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 43, 607-616 (1999).
21. Xu, L., Pirollo, K. F., Tang, W. H., Rait, A., and Chang, E. H. Transferrin-liposome-mediated Systemic p53 Gene Therapy in Combination With Radiation Results in Regression of Human Head and Neck Cancer Xenografts. Hum. Gene Ther. 10, 2941-2952 (1999).
22. Wakasa, T., Inoue, T., Kawai, N., Murakami, J., Kishi, K., and Fukui, K. The Combination of Ionizing Radiation and Expression of a Wild Type p53 Gene via Recombinant Adenovirus Induced a Prominent Tumour Suppressing Effect in Human Oral Squamous Cell Carcinoma. Br. J. Radiol. 75, 657-662 (2002).
23. Higuchi, Y., Asaumi, J., Murakami, J., Matsuzaki, H., Wakasa, T., Inoue, T., Shigehara, H., Konouchi, H., Hisatomi, M., Kawasaki, S., Hiraki, Y., and Kishi, K. Effects of p53 Gene Therapy in Radiotherapy or Thermotherapy of Human Head and Neck Squamous Cell Carcinoma Cell Lines. Oncol. Rep. 10, 671-677 (2003).
24. Swisher, S. G. and Roth, J. A. Clinical Update of Ad-p53 Gene Therapy for Lung Cancer. Surg. Oncol. Clin. N. Am. 11, 521-535 (2002).
25. Swisher, S. G., Roth, J. A., Komaki, R., Gu, J., Lee, J. J., Hicks, M., Ro, J. Y., Hong, W. K., Merritt, J. A., Ahrar, K., Atkinson, N. E., Correa, A. M., Dolormente, M., Dreiling, L., El-Naggar, A. K., Fossella, F., Francisco, R., Glisson, B., Grammer, S., Herbst, R., Huaringa, A., Kemp, B., Khuri, F. R., Kurie, J. M., Liao, Z., McDonnell, T. J., Morice, R., Morello, F., Munden, R., Papadimitrakopoulou, V., Pisters, K. M., Putnam, J. B., Jr, Sarabia, A. J., Shelton, T., Stevens, C., Shin, D. M., Smythe, W. R., Vaporciyan, A. A., Walsh, G. L., and Yin, M. Induction of p53-regulated Genes and Tumor Regression in Lung Cancer Patients After Intratumoral Delivery of Adenoviral p53 (INGN 201) and Radiation Therapy. Clin. Cancer Res. 9, 93-101 (2003).
26. Sasaki, Y., Morimoto, I., Ishida, S., Yamashita, T., Imai, K., and Tokino, T. Adenovirus-mediated Transfer of the p53 Family Genes, p73 and p51/p63 Induces Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cell Lines: Potential Application to Gene Therapy of Colorectal Cancer. Gene Ther. 8, 1401-1408 (2001).
27. Naumann, U., Kugler, S., Wolburg, H., Wick, W., Rascher, G., Schulz, J. B., Conseiller, E., Bahr, M., and Weller, M. Chimeric Tumor Suppressor 1, A p53-derived Chimeric Tumor Suppressor Gene, Kills p53 Mutant and p53 Wild-type Glioma Cells in Synergy with Irradiation and CD95 Ligand. Cancer Res. 61, 5833-5842 (2001).
28. Kawabe, S., Roth, J. A., Wilson, D. R., and Meyn, R. E. Adenovirus-mediated p16INK4a Gene Expression Radiosensitizes Non-small cell Lung Cancer Cells in a p53-dependent Manner. Oncogene 79, 5359-5366 (2000).
29. Gao, N., Hu, Y. D., Cao, X. Y., Zhou, J., and Cao, S. L. The Exogenous Wild-type p14ARF Gene Induces Growth Arrest and Promotes Radiosensitivity in Human Lung Cancer Cell Lines. J. Cancer Res. Clin. Oncol. 127, 359-367 (2001).
30. Fueyo, J., Gomez-Manzano, C., Yung, W. K., Liu, T. J., Alemany, R., McDonnell, T. J., Shi, X., Rao, J. S., Levin, V. A., and Kyritsis, A. P. Overexpression of E2F-1 in Glioma Triggers Apoptosis and Suppresses Tumor Growth In Vitro and In Vivo. Nat. Med. 4, 685-690 (1998).
31. Dong, Y. B., Yang, H. L., Elliott, M. J., and McMasters, K. M. Adenovirus-mediated E2F-1 Gene Transfer Sensitizes Melanoma Cells to Apoptosis Induced by Topoisomerase II Inhibitors. Cancer Res.62, 1776-1783 (2002).
32. Li, A. A., Ng, E., Shi, W., Lee, A., Chia, M., Liu, T. J., Huang, D., O'Sullivan, B., Gullane, P., and Liu, F. F. Potential Efficacy of p16 Gene Therapy for EBV-positive Nasopharyngeal Carcinoma. Int. J. Cancer 110, 452-458 (2004).
33. McKenzie, T., Liu, Y., Fanale, M., Swisher, S. G., Chada, S., and Hunt, K. K. Combination Therapy of Ad-mda7 and Trastuzumab Increases Cell Death in Her-2/neu-overexpressing Breast Cancer Cells. Surgery 136, 437-442 (2004).
34. Lebedeva, I. V., Su, Z. Z., Chang, Y., Kitada, S., Reed, J. C., and Fisher, P. B. The Cancer Growth Suppressing Gene mda-7 Induces Apoptosis Selectively in Human Melanoma Cells. Oncogene 21, 708-718 (2002).
35. Leath, C. A ., 3rd, Kataram, M., Bhagavatula, P., Gopalkrishnan, R. V., Dent, P., Fisher, P. B., Pereboev, A., Carey, D., Lebedeva, I. V., Haisma, H. J., Alvarez, R. D., Curiel, D. T., and Mahasreshti, P. J. Infectivity Enhanced Adenoviral-mediated mda-7/IL-24 Gene Therapy for Ovarian Carcinoma. Gynecol. Oncol. 94, 352-362 (2004).
36. Su, Z., Lebedeva, I. V., Gopalkrishnan, R. V., Goldstein, N. I., Stein, C. A., Reed, J. C., Dent, P., and Fisher, P. B. A Combinatorial Approach for Selectively Inducing Programmed Cell Death in Human Pancreatic Cancer Cells. Proc. Natl. Acad. Sci. U.S.A. 98, 10332-10337 (2001).
37. Saeki, T., Mhashilkar, A., Chada, S., Branch, C., Roth, J. A., and Ramesh, R. Tumor-suppressive Effects by Adenovirus-mediated mda-7 Gene Transfer in Non-small Cell Lung Cancer Cell In Vitro. Gene Ther. 7, 2051-2057 (2000).
38. Nishikawa, T., Ramesh, R., Munshi, A., Chada, S., and Meyn, R. E. Adenovirus-mediated mda-7 (IL24) Gene Therapy Suppresses Angiogenesis and Sensitizes NSCLC Xenograft Tumors to Radiation. Mol. Ther. 9, 818-828 (2004).
39. Nishitani, M. A., Sakai, T., Ishii, K., Zhang, M., Nakano, Y., Nitta, Y., Miyazaki, J., Kanayama, H. O., Kagawa, S., and Himeno, K. A Convenient Cancer Vaccine Therapy with In Vivo Transfer of Interleukin 12 Expression Plasmid Using Gene Gun Technology After Priming with Irradiated Carcinoma Cells. Cancer Gene Ther. 9, 156-163 (2002).
40. Sarti, M., Sevignani, C., Calin, G. A., Aqeilan, R., Shimizu, M., Pentimalli, F., Picchio, M. C., Godwin, A., Rosenberg, A., Drusco, A., Negrini, M., and Croce, C. M. Adenoviral Transduction of TESTIN Gene into Breast and Uterine Cancer Cell Lines Promotes Apoptosis and Tumor Reduction In Vivo. Clin. Cancer Res. 11, 806-813 (2005).
41. Mao, X., Seidlitz, E., Truant, R., Hitt, M., and Ghosh, H. P. Reexpression of TSLC1 in a Non-small-cell Lung Cancer Cell Line Induces Apoptosis and Inhibits Tumor Growth. Oncogene 23, 5632-5642 (2004).
42. Winter, R. N., Rhee, J. G., and Kyprianou, N. Caspase-1 Enhances the Apoptotic Response of Prostate Cancer Cells to Ionizing Radiation. Anticancer Res. 24, 1377-1386 (2004).
43. Shariat, S. F., Desai, S., Song, W., Khan, T., Zhao, J., Nguyen, C., Foster, B. A., Greenberg, N., Spencer, D. M., and Slawin, K. M. Adenovirus-mediated Transfer of Inducible Caspases: A Novel "Death Switch" Gene Therapeutic Approach to Prostate Cancer. Cancer Res. 61, 2562-2571 (2001).
44. Uchida, H., Shinoura, N., Kitayama, J., Watanabe, T., Nagawa, H., and Hamada, H. Caspase-8 gene Transduction Augments Radiation-induced Apoptosis in DLD-1 Cells. Biochem. Biophys. Res. Commun. 292, 347-354 (2002).
45. Yanamandra, N., Kondraganti, S., Srinivasula, S. M., Gujrati, M., Olivero, W. C., Dinh, D. H., and Rao, J. S. Activation of caspase-9 with Irradiation Inhibits Invasion and Angiogenesis in SNB19 Human Glioma Cells. Oncogene 23, 2339-2346 (2004).
46. Shinoura, N., Yamamoto, N., Asai, A., Kirino, T., and Hamada, H. Adenovirus-mediated Transfer of Fas Ligand Gene Augments Radiation-induced Apoptosis in U-373MG Glioma Cells. Jpn. J. Cancer Res. 91, 1044-1050 (2000).
47. Yip, K. W., Li, A., Li, J. H., Shi, W., Chia, M. C., Rashid, S. A., Mocanu, J. D., Louie, A. V., Sanchez, O., Huang, D., Busson, P., Yeh, W. C., Gilbert, R., O'sullivan, B., Gullane, P., and Liu, F. F. Potential Utility of BimS as a Novel Apoptotic Therapeutic Molecule. Mol. Ther. 10, 533-544 (2004).
48. Fecker, L. F., Geilen, C. C., Hossini, A. M., Schwarz, C., Fechner, H., Bartlett, D. L., Orfanos, C. E., and Eberle, J. Selective Induction of Apoptosis in Melanoma Cells by Tyrosinase Promoter-controlled CD95 Ligand Overexpression. J. Invest. Dermatol. 124, 221-228 (2005).
49. Kaliberov, S. A., Kaliberova, L. N., Stockard, C. R., Grizzle, W. E., and Buchsbaum, D. J. Adenovirus-mediated FLT1-targeted Proapoptotic Gene Therapy of Human Prostate Cancer. Mol. Ther. 10, 1059-1070 (2004).
50. Hara, T., Omura-Minamisawa, M., Chao, C., Nakagami, Y., Ito, M., and Inoue, T. Bcl-2 Inhibitors Potentiate the Cytotoxic Effects of Radiation in Bcl-2 Overexpressing Radioresistant Tumor Cells. Int. J. Radiat. Oncol. Biol. Phys. 67, 517-528 (2005).
51. Mercatante, D. R., Mohler, J. L., and Kole, R. Cellular Response to an Antisense-mediated Shift of Bcl-x pre-mRNA Splicing and Antineoplastic Agents. J. Biol. Chem. 277, 49374-49382 (2002).
52. Cao, C., Mu, Y., Hallahan, D. E., and Lu, B. XIAP and Survivin as Therapeutic Targets for Radiation Sensitization in Preclinical Models of Lung Cancer. Oncogene 23, 7047-7052 (2004).
53. Sakakura, C., Sweeney, E. A., Shirahama, T., Igarashi, Y., Hakomori, S., Nakatani, H., Tsujimoto, H., Imanishi, T., Ohgaki, M., Ohyama, T., Yamazaki, J., Hagiwara, A., Yamaguchi, T., Sawai, K., and Takahashi, T. Overexpression of bax Sensitizes Human Breast Cancer MCF-7 Cells to Radiation-induced Apoptosis. Int. J. Cancer 67, 101-105 (1996).
54. Sakakura, C., Sweeney, E. A., Shirahama, T., Igarashi, Y., Hakomori, S., Tsujimoto, H., Imanishi, T., Ohgaki, M., Yamazaki, J., Hagiwara, A., Sawai, K., Yamaguchi, T., and Takahashi, T. Overexpression of bax Enhances the Radiation Sensitivity in Human Breast Cancer Cells. Surg. Today 27, 90-93 (1997).
55. Arafat, W. O., Gomez-Navarro, J., Xiang, J., Barnes, M. N., Mahasreshti, P., Alvarez, R. D., Siegal, G. P., Badib, A. O., Buchsbaum, D., Curiel, D. T., and Stackhouse, M. A. An Adenovirus Encoding Proapoptotic Bax Induces Apoptosis and Enhances the Radiation Effect in Human Ovarian Cancer. Mol. Ther. 1, 545-554 (2000).
56. Kim, R., Inoue, H., and Toge, T. Bax is an Important Determinant for Radiation Sensitivity in Esophageal Carcinoma Cells. Int. J. Mol. Med. 14, 697-706 (2004).
57. Arafat, W. O., Buchsbaum, D. J., Gomez-Navarro, J., Tawil, S. A., Olsen, C., Xiang, J., El-Akad, H., Salama, A. M., Badib, A. O., Stackhouse, M. A., and Curiel, D. T. An Adenovirus Encoding Proapoptotic Bax Synergistically Radiosensitizes Malignant Glioma. Int. J. Radiat. Oncol. Biol. Phys. 55, 1037-1050 (2003).
58. Gomez-Navarro, J., Arafat, W., and Xiang, J. Gene Therapy for Carcinoma of the Breast: Pro-apoptotic Gene Therapy. Breast Cancer Res. 2, 32-44 (2000).
59. Takeuchi, H., Kanzawa, T., Kondo, Y., Komata, T., Hirohata, S., Kyo, S., and Kondo, S. Combination of Caspase Transfer Using the Human Telomerase Reverse Transcriptase Promoter and Conventional Therapies for Malignant Glioma Cells. Int. J. Oncol. 25, 57-63 (2004).
60. Weichselbaum, R. R., Hallahan, D. E., Beckett, M. A., Mauceri, H. J., Lee, H., Sukhataie, V. P., and Kufe, D. W. Gene Therapy Targeted by Radiation Preferentially Radiosensitizes Tumor Cells. Cancer Res. 54, 4266-4269 (1994).
61. Gridley, D. S., Andres, M. L., Garner, C., Mao, X. W., and Slater, J. M. Evaluation of TNF-alpha Effects on Radiation Efficacy in a Human Lung Adenocarcinoma Model. Oncol. Res. 8, 485-495 (1996).
62. Gridley, D. S., Li, J., Kajioka, E. H., Andres, M. L., Moyers, M. F., and Slater, J. M. Combination of pGL1-TNF-alpha Gene and Radiation (Proton and Gamma-ray) Therapy Against Brain Tumor. Anticancer Res. 20, 4195-4203 (2000).
63. Gridley, D. S., Baer, J. R., Cao, J. D., Miller, G. M., Kim, D. W., Timiryasova, T. M., Fodor, I., and Slater, J. M. TNF-alpha Gene and Proton Radiotherapy in an Orthotopic Brain Tumor Model. Int. J. Oncol. 21, 251-259 (2002).
64. Gridley, D. S., Miller, G. M., Luo, X., Cao, J. D., Timiryasova, T. M., Fodor, I., and Slater, J. M. Proton Radiation and TNF-alpha/Bax Gene Therapy for Orthotopic C6 Brain Tumor in Wistar Rats. Technol. Cancer. Res. Treat. 3, 217-227 (2004).
65. Weichselbaum, R. R., Kufe, D. W., Hellman, S., Rasmussen, H. S., King, C. R., Fischer, P. H., and Mauceri, H. J. Radiation-induced Tumour Necrosis Factor-alpha Expression: Clinical Application of Transcriptional and Physical Targeting of Gene Therapy. Lancet Oncol. 3, 665-671 (2002).
66. Kircheis, R. and Wagner, E. Technology Evaluation: TNFerade, GenVec. Curr. Opin. Mol. Ther. 5, 437-447 (2003).
67. Howard-Flanders, P. Effect of Nitric Oxide on the Radiosensitivity of Bacteria. Nature 180, 1191-1192 (1957).
68. Mitchell, J. B., Cook, J. A., Krishna, M. C., DeGraff, W., Gamson, J., Fisher, J., Christodoulou, D., and Wink, D. A. Radiation Sensitization by Nitric Oxide Releasing Agents. Br. J. Cancer Suppl. 27, S181-4 (1996).
69. Mitchell, J. B., DeGraff, W., Kim, S., Cook, J. A., Gamson, J., Christodoulou, D., Feelisch, M., and Wink, D. A. Redox Generation of Nitric oxide to Radiosensitize Hypoxic Cells. Int. J. Radiat. Oncol. Biol. Phys. 42, 795-798 (1998).
70. Worthington, J., Robson, T., O'Keeffe, M., and Hirst, D. G. Tumour Cell Radiosensitization Using Constitutive (CMV) and Radiation Inducible (WAF1) Promoters to Drive the iNOS Gene: A Novel Suicide Gene Therapy. Gene Ther. 9, 263-269 (2002).
71. Worthington, J., McCarthy, H. O., Barrett, E., Adams, C., Robson, T., and Hirst, D. G. Use of the Radiation-inducible WAF1 Promoter to Drive iNOS Gene Therapy as a Novel Anti-cancer Treatment. J. Gene Med. 6, 673-680 (2004).
72. Worthington, J., Robson, T., Scott, S., and Hirst, D. G. Evaluation of a Synthetic CArG Promoter for Nitric Oxide Synthase Gene Therapy of Cancer. Gene Therapy (in press).
73. Cook, T., Wang, Z., Alber, S., Liu, K., Watkins, S. C., Vodovotz, Y., Billiar, T. R., and Blumberg, D. Nitric Oxide and Ionizing Radiation Synergistically Promote Apoptosis and Growth Inhibition of Cancer by Activating p53. Cancer Res. 64, 8015-8021 (2004).
74. Kuroki, M. Gene Therapy in Cancer via Use of a Retrovector Having a Tumor Specificity and Expressing Inducible Nitric Oxide Synthase. Methods Mol. Biol. 279, 201-211 (2004).
75. Juang, S. H., Xie, K., Xu, L., Shi, Q., Wang, Y., Yoneda, J., and Fidler, I. J. Suppression of Tumorigenicity and Metastasis of Human Renal Carcinoma Cells by Infection with Retroviral Vectors Harboring the Murine Inducible Nitric Oxide Synthase Gene. Hum. Gene Ther. 9, 845-854 (1998).
76. Pope, I. M., Poston, G. J., and Kinsella, A. R. The Role of the Bystander Effect in Suicide Gene Therapy. Eur. J. Cancer 33, 1005-1016 (1997).
77. van Dillen, I. J., Mulder, N. H., Vaalburg, W., de Vries, E. F., and Hospers, G. A. Influence of the Bystander Effect on HSV-tk/GCV Gene Therapy. A Review. Curr. Gene Ther. 2, 307-322 (2002).
78. Denny, W. A. Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy). J. Biomed. Biotechnol. 2003, 48-70 (2003).
79. McKeown, S. R., Ward, C., and Robson, T. Gene-directed Enzyme Prodrug Therapy. A Current Assessment. Curr. Opin. Mol. Ther. 6, 421-435 (2004).
80. Villarreal, E. C. Current and Potential Therapies for the Treatment of Herpes-virus Infections. Prog. Drug Res. 60, 263-307 (2003).
81. Kim, J. H., Kim, S. H., Brown, S. L., and Freytag, S. O. Selective Enhancement by an Antiviral Agent of the Radiation-induced Cell Killing of Human Glioma Cells Transduced with HSV-tk Gene. Cancer Res. 54, 6053-6056 (1994).
82. Kim, J. H., Kim, S. H., Kolozsvary, A., Brown, S. L., Kim, O. B., and Freytag, S. O. Selective Enhancement of Radiation Response of Herpes Simplex Virus Thymidine Kinase Transduced 9L Gliosarcoma Cells In Vitro and In Vivo by Antiviral Agents. Int. J. Radiat. Oncol. Biol. Phys. 33, 861-868 (1995).
83. Vlachaki, M. T., Chhikara, M., Aguilar, L., Zhu, X., Chiu, K. J., Woo, S., Teh, B. S., Thompson, T. C., Butler, E. B., and Aguilar-Cordova, E. Enhanced Therapeutic Effect of Multiple Injections of HSV-TK + GCV Gene Therapy in Combination with Ionizing Radiation in a Mouse Mammary Tumor Model. Int. J. Radiat. Oncol. Biol. Phys. 51, 1008-1017 (2001).
84. Kanazawa, T., Mizukami, H., Okada, T., Hanazono, Y., Kume, A., Nishino, H., Takeuchi, K., Kitamura, K., Ichimura, K., and Ozawa, K. Suicide Gene Therapy Using AAV-HSVtk/ganciclovir in Combination with Irradiation Results in Regression of Human Head and Neck Cancer Xenografts in Nude Mice. Gene Ther. 10, 51-58 (2003).
85. Greco, O., Powell, T. M., Marples, B., Joiner, M. C., and Scott, S. D. Gene Therapy Vectors Containing CArG Elements from the Egr1 Gene are Activated by Neutron Irradiation, Cisplatin and Doxorubicin. Cancer Gene Ther. (2005).
86. Khil, M. S., Kim, J. H., Mullen, C. A., Kim, S. H., and Freytag, S. O. Radiosensitization by 5-fluorocytosine of Human Colorectal Carcinoma Cells in Culture Transduced with Cytosine Deaminase Gene. Clin. Cancer Res. 2, 53-57 (1996).
87. Hanna, N. N., Mauceri, H. J., Wayne, J. D., Hallahan, D. E., Kufe, D. W., and Weichselbaum, R. R. Virally Directed Cytosine Deaminase/5-fluorocytosine Gene Therapy Enhances Radiation Response in Human Cancer Xenografts. Cancer Res. 57, 4205-4209 (1997).
88. Zhang, Z., Shirakawa, T., Hinata, N., Matsumoto, A., Fujisawa, M., Okada, H., Kamidono, S., Matsuo, M., and Gotoh, A. Combination with CD/5-FC Gene Therapy Enhances Killing of Human Bladder-cancer Cells by Radiation. J. Gene Med. 5, 860-867 (2003).
89. Adachi, Y., Tamiya, T., Ichikawa, T., Terada, K., Ono, Y., Matsumoto, K., Furuta, T., Hamada, H., and Ohmoto, T. Experimental Gene Therapy for Brain Tumors Using Adenovirus-mediated Transfer of Cytosine Deaminase Gene and Uracil Phosphoribosyltransferase Gene with 5-fluorocytosine. Hum. Gene Ther. 11, 77-89 (2000).
90. Kambara, H., Tamiya, T., Ono, Y., Ohtsuka, S., Terada, K., Adachi, Y., Ichikawa, T., Hamada, H., and Ohmoto, T. Combined Radiation and Gene Therapy for Brain Tumors with Adenovirus-mediated Transfer of Cytosine Deaminase and Uracil Phosphoribosyltransferase Genes. Cancer Gene Ther. 9, 840-845 (2002).
91. Rogulski, K. R., Kim, J. H., Kim, S. H., and Freytag, S. O. Glioma Cells Transduced with an Escherichia coli CD/HSV-1 TK Fusion Gene Exhibit Enhanced Metabolic Suicide and Radiosensitivity. Hum. Gene Ther. 8, 73-85 (1997).
92. Ueno, M., Koyama, F., Yamada, Y., Fujimoto, H., Takayama, T., Kamada, K., Naito, A., Hirao, S., Mukogawa, T., Hamada, H., and Nakajima, Y. Tumor-specific Chemo-radio-gene Therapy for Colorectal Cancer Cells Using Adenovirus Vector Expressing the Cytosine Deaminase Gene. Anticancer Res. 21, 2601-2608 (2001).
93. Lee, Y J., Lee, H., and Borrelli, M. J. Gene Transfer into Human Prostate Adenocarcinoma Cells with an Adenoviral Vector: Hyperthermia Enhances a Double Suicide Gene Expression, Cytotoxicity and Radiotoxicity. Cancer Gene Ther. 9, 267-274 (2002).
94. Xia, K., Liang, D., Tang, A., Feng, Y., Zhang, J., Pan, Q., Long, Z., Dai, H., Cai, F., Wu, L., Zhao, S., Chen, Z., and Xia, J. A Novel Fusion Suicide Gene Yeast CDglyTK Plays a Role in Radio-gene Therapy of Nasopharyngeal Carcinoma. Cancer Gene Ther. II, 790-796 (2004).
95. de Melo, M. P., de Lima, T. M., Pithon-Curi, T. C., and Curi, R. The Mechanism of Indole Acetic Acid Cytotoxicity. Toxicol. Lett. 148, 103-111 (2004).
96. Greco, O., Tozer, G. M., and Dachs, G. U. Oxic and Anoxic Enhancement of Radiation-mediated Toxicity by Horseradish Peroxidase/indole-3-acetic Acid Gene Therapy. Int. J. Radiat. Biol. 75, 173-181 (2002).
97. Hockel, M. and Vaupel, P. Biological Consequences of Tumor Hypoxia. Semin. Oncol. 28, 36-41 (2001).
98. Movsas, B. Quality of Life in Oncology Trials: A Clinical Guide. Semin. Radiat. Oncol. 13, 235-247 (2003).
99. Vaupel, P. and Harrison, L. Tumor Hypoxia: Causative Factors, Compensatory Mechanisms, and Cellular Response. Oncologist 9, 4-9 (2004).
100. Subarsky, P. and Hill, R. P. The Hypoxic Tumour Microenvironment and Metastatic Progression. Clin. Exp. Metastasis 20, 237-250 (2003).
101. McKeown, S. R., Hejmadi, M. V., McIntyre, I. A., McAleer, J. J., and Patterson, L. H. AQ4N: an Alkylaminoanthraquinone N-oxide Showing Bioreductive Potential and Positive Interaction with Radiation In Vivo. Br. J. Cancer 72, 76-81 (1995).
102. McKeown, S. R., Friery, O. P., McIntyre, I. A., Hejmadi, M. V., Patterson, L. H., and Hirst, D. G. Evidence for a Therapeutic Gain When AQ4N or Tirapazamine is Combined with Radiation. Br. J. Cancer Suppl. 27, S39-42 (1996).
103. Gallagher, R., Hughes, C. M., Murray, M. M., Friery, O. P., Patterson, L. H., Hirst, D. G., and McKeown, S. R. The Chemopotentiation of Cisplatin by the Novel Bioreductive Drug AQ4N. Br. J. Cancer 85, 625-629 (2001).
104. Friery, O. P., Gallagher, R., Murray, M. M., Hughes, C. M., Galligan, E. S., McIntyre, I. A., Patterson, L. H., Hirst, D. G., and McKeown, S. R. Enhancement of the Anti-tumour Effect of Cyclophosphamide by the Bioreductive Drugs AQ4N and Tirapazamine. Br. J. Cancer 82, 1469-1473 (2000).
105. McCarthy, H. O., Yakkundi, A., McErlane, V., Hughes, C. M., Keilty, G., Murray, M., Patterson, L. H., Hirst, D. G., McKeown, S. R., and Robson, T. Bioreductive GDEPT Using Cytochrome P450 3A4 in Combination with AQ4N. Cancer Gene Ther. 10, 40-48 (2003).
106. McErlane, V., Yakkundi, A., McCarthy, H. O., Hughes, C. M., Patterson, L. H., Hirst, D. G., Robson, T., and McKeown, S. R. A Cytochrome P450 2B6 Meditated Gene Therapy Strategy to Enhance the Effects of Radiation or Cyclophosphamide When Combined with the Bioreductive Drug AQ4N. J. Gene Med. (2005).
107. Cowen, R. L., Williams, K. J., Chinje, E. C., Jaffar, M., Sheppard, F. C., Telfer, B. A., Wind, N. S., and Stratford, I. J. Hypoxia Targeted Gene Therapy to Increase the Efficacy of Tirapazamine as an Adjuvant to Radiotherapy: Reversing Tumor Radioresistance and Effecting Cure. Cancer Res. 64, 1396-1402 (2004).
108. Cowen, R. L., Patterson, A. V., Telfer, B. A., Airley, R. E., Hobbs, S., Phillips, R. M., Jaffar, M., Stratford, I. J., and Williams, K. J. Viral Delivery of P450 Reductase Recapitulates the Ability of Constitutive Overexpression of Reductase Enzymes to Potentiate the Activity of Mitomycin C in Human Breast Cancer Xenografts. Mol. Cancer. Ther. 2, 901-909 (2003).
109. Jounaidi, Y. and Waxman, D. J. Combination of the Bioreductive Drug Tirapazamine With the Chemotherapeutic Prodrug Cyclophosphamide for P450/P450-reductase-based Cancer Gene Therapy. Cancer Res. 60, 3761-3769 (2000).
110. Rainov, N. G. A Phase III Clinical Evaluation of Herpes Simplex Virus Type 1 Thymidine Kinase and Ganciclovir Gene Therapy as an Adjuvant to Surgical Resection and Radiation in Adults with Previously Untreated Glioblastoma Multiforme. Hum. Gene Ther. 11, 2389-2401 (2000).
111. Teh, B. S., Aguilar-Cordova, E., Kernen, K., Chou, C. C., Shalev, M., Vlachaki, M. T., Miles, B., Kadmon, D., Mai, W. Y., Caillouet, I., Davis, M., Ayala, G., Wheeler, T., Brady, I., Carpenter, L. S., Lu, H. H., Chia, J. K., Woo, S. Y., Thompson, T., and Butler, E. B. Phase I/II Trial Evaluating Combined Radiotherapy and In Situ Gene Therapy With or Without Hormonal Therapy in the Treatment of Prostate Cancer - A Preliminary Report. Int. J. Radiat. Oncol. Biol. Phys. 51, 605-613 (2001).
112. Teh, B. S., Ayala, G., Aguilar, L., Mai, W. Y., Timme, T. L., Vlachaki, M. T., Miles, B., Kadmon, D., Wheeler, T., Caillouet, J., Davis, M., Carpenter, L. S., Lu, H. H., Chiu, J. K., Woo, S. Y., Thompson, T., Aguilar-Cordova, E., and Butler, E. B. Phase I-II Trial Evaluating Combined Intensity-modulated Radiotherapy and In Situ Gene Therapy With or Without Hormonal Therapy in Treatment of Prostate Cancer-interim Report on PSA Response and Biopsy Data. Int. J. Radiat. Oncol. Biol. Phys. 58, 1520-1529 (2004).
113. Chiocca, E. A. Oncolytic Viruses. Nat. Rev. Cancer. 2, 938-950 (2002).
114. Hawkins, L. K., Lemoine, N. R., and Kim, D. Oncolytic Biotherapy: A Novel Therapeutic Plafform. Lancet Oncol. 3, 17-26 (2002).
115. Geoerger, B., Grill, J., Opolon, P., Morizet, J., Aubert, G., Lecluse, Y., van Beusechem, V. W., Gerritsen, W. R., Kim, D. H., and Vassal, G. Potentiation of Radiation Therapy by the Oncolytic Adenovirus d11520 (ONYX-015) in Human Malignant Glioma Xenografts. Br. J. Cancer 89, 577-584 (2003).
116. Rogulski, K. R., Freytag, S. O., Zhang, K., Gilbert, J. D., Paielli, D. L., Kim, J. H., Heise, C. C., and Kim, D. H. In Vivo Antitumor Activity of ONYX-015 is Influenced by p53 Status and is Augmented by Radiotherapy. Cancer Res. 60, 1193-1196 (2000).
117. Chia, M. C., Shi, W., Li, J. H., Sanchez, O., Strathdee, C. A., Huang, D., Busson, P., Klamut, H. J., and Liu, F. F. A Conditionally Replicating Adenovirus for Nasopharyngeal Carcinoma Gene Therapy. Mol. Ther. 9, 804-817 (2004).
118. Toth, K., Tarakanova, V., Doronin, K., Ward, P., Kuppuswamy, M., Locke, J. E., Dawson, J. E., Kim, H. J., and Wold, W. S. Radiation Increases the Activity of Oncolytic Adenovirus Cancer Gene Therapy Vectors that Overexpress the ADP (E3-11.6K) Protein. Cancer Gene Ther. 10, 193-200 (2003).
119. Lamfers, M. L., Grill, J., Dirven, C. M., Van Beusechem, V. W., Geoerger, B., Van Den Berg, J., Alemany, R., Fueyo, J., Curiel, D. T., Vassal, G., Pinedo, H. M., Vandertop, W. P., and Gerritsen, W. R. Potential of the Conditionally Replicative Adenovirus Ad5-Delta24RGD in the Treatment of Malignant Gliomas and its Enhanced Effect with Radiotherapy. Cancer Res. 62, 5736-5742 (2002).
120. DeWeese, T. L., van der Poel, H., Li, S., Mikhak, B., Drew, R., Goemann, M., Hamper, U., DeJong, R., Detorie, N., Rodriguez, R., Haulk, T., DeMarzo, A. M., Piantadosi, S., Yu, D. C., Chen, Y., Henderson, D. R., Carducci, M. A., Nelson, W. G., and Simons, J. W. A Phase I Trial of CV706, A Replication-competent, PSA Selective Oncolytic Adenovirus, for the Treatment of Locally Recurrent Prostate Cancer Following Radiation Therapy. Cancer Res. 61, 7464-7472 (2001).
121. Kim, S. H., Wong, R. J., Kooby, D. A., Carew, J. F., Adusumilli, P. S., Patel, S. G., Shah, J. P., and Fong, Y. Combination of Mutated Herpes Simplex Virus Type 1 (G207 virus) with Radiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck. Eur. J. Cancer 41, 313-322 (2005).
122. Freytag, S. O., Khil, M., Stricker, H., Peabody, J., Menon, M., DePeralta-Venturina, M., Nafziger, D., Pegg, J., Paielli, D., Brown, S., Barton, K., Lu, M., Aguilar-Cordova, E., and Kim, J. H. Phase I Study of Replication-competent Adenovirus-mediated Double Suicide Gene Therapy for the Treatment of Locally Recurrent Prostate Cancer. Cancer Res. 62, 4968-4976 (2002).
123. Freytag, S. O., Paielli, D., Wing, M., Rogulski, K., Brown, S., Kolozsvary, A., Seely, J., Barton, K., Dragovic, A., and Kim, J. H. Efficacy and Toxicity of Replication-competent Adenovirus-mediated Double Suicide Gene Therapy in Combination with Radiation Therapy in an Orthotopic Mouse Prostate Cancer Model. Int. J. Radiat. Oncol. Biol. Phys. 54, 873-885 (2002).
124. Freytag, S. O., Stricker, H., Pegg, J., Paielli, D., Pradhan, D. G., Peabody, J., DePeralta-Venturina, M., Xia, X., Brown, S., Lu, M., and Kim, J. H. Phase I Study of Replication-competent Adenovirus-mediated Double-suicide Gene Therapy in Combination with Conventional-dose Three-dimensional Conformal Radiation Therapy for the Treatment of Newly Diagnosed, Intermediate- to high-risk Prostate Cancer. Cancer Res. 63, 7497-7506 (2003).
125. Rogulski, K. R., Wing, M. S., Paielli, D. L., Gilbert, J. D., Kim, J. H., and Freytag, S. O. Double Suicide Gene Therapy Augments the Antitumor Activity of a Replication-competent Lytic Adenovirus Through Enhanced Cytotoxicity and Radiosensitization. Hum. Gene Ther. 11, 67-76 (2000).
126. Robson, T. and Hirst, D. G. Transcriptional Targeting in Cancer Gene Therapy. J. Biomed. Biotechnol. 2003, 110-137 (2003).
127. Kim, S. H., Kim, J. H., and Djordjevic, B. Effects of X-irradiation on RNA and Protein Synthesis in HeLa Cells. Radiat. Res. 42, 577-589 (1970).
128. Leonardsson, G. and Ny, T. Characterization of the Rat Tissue-type Plasminogen Activator Gene Promoter - Identification of a TAAT-containing Promoter Element. Eur. J. Biochem. 248, 676-683 (1997).
129. Boothman, D. A., Wang, M., and Lee, S. W. Induction of Tissue-type Plasminogen Activator by Ionizing Radiation in Human Malignant Melanoma Cells. Cancer Res. 51, 5587-5595 (1991).
130. Boothman, D. A., Lee, I. W., and Sahijdak, W. M. Isolation of an X-ray-responsive Element in the Promoter Region of Tissue-type Plasminogen Activator: Potential Uses of X-ray-responsive Elements for Gene Therapy. Radiat. Res. 138, S68-71 (1994).
131. Christov, A., Ottman, J. T., and Grammas, P. Vascular Inflammatory, Oxidative and Protease-based Processes: Implications for Neuronal Cell Death in Alzheimer's Disease. Neurol. Res. 26, 540-546 (2004).
132. Hallahan, D. E., Sukhatme, V. P., Sherman, M. L., Virudachalam, S., Kufe, D., and Weichselbaum, R. R. Protein Kinase C Mediates X-ray Inducibility of Nuclear Signal Transducers EGR1 and JUN. Proc. Natl. Acad. Sci. U.S.A. 88, 2156-2160 (1991).
133. Datta, R., Taneja, N., Sukhatme, V. P., Qureshi, S. A., Weichselbaum, R., and Kufe, D. W. Reactive Oxygen Intermediates Target CC(A/T)6GG Sequences to Mediate Activation of the Early Growth Response 1 Transcription Factor Gene by Ionizing Radiation. Proc. Natl. Acad. Sci. USA. 90, 2419-2422 (1993).
134. Hallahan, D. E., Mauceri, H. J., Seung, L. P., Dunphy, E. J., Wayne, J. D., Hanna, N. N., Toledano, A., Hellman, S., Kufe, D. W., and Weichselbaum, R. R. Spatial and Temporal Control of Gene Therapy Using Ionizing Radiation. Nat. Med. 1, 786-791 (1995).
135. Senzer, N., Mani, S., Rosemurgy, A., Nemunaitis, J., Cunningham, C., Guha, C., Bayol, N., Gillen, M., Chu, K., Rasmussen, C., Rasmussen, H., Kufe, D., Weichselbaum, R., and Hanna, N. TNFerade Biologic, An Adenovector with a Radiation-inducible Promoter, Carrying the Human Tumor Necrosis Factor Alpha Gene: A Phase I Study in Patients with Solid Tumors. J. Clin. Oncol. 22, 592-601 (2004).
136. Scott, S. D., Joiner, M. C., and Marples, B. Optimizing Radiation-responsive Gene Promoters for Radiogenetic Cancer Therapy. Gene Ther. 9, 1396-1402 (2002).
137. Scott, S. D., Marples, B., Hendry, J. H., Lashford, L. S., Embleton, M. J., Hunter, R. D., Howell, A., and Margison, G. P. A Radiation-controlled Molecular Switch for Use in Gene Therapy of Cancer. Gene Ther. 7, 1121-1125 (2000).
138. Greco, O., Marples, B., Dachs, G. U., Williams, K. J., Patterson, A. V., and Scott, S. D. Novel Chimeric Gene Promoters Responsive to Hypoxia and Ionizing Radiation. Gene Ther. 9, 1403-1411 (2002).
139. Scott, S. D. and Greco, O. Radiation and Hypoxia Inducible Gene Therapy Systems. Cancer Metastasis Rev. 23, 269-276 (2004).
140. Hsu, H., Rainov, N. G., Quinones, A., Eling, D. J., Sakamoto, K. M., and Spear, M. A. Combined Radiation and Cytochrome CYP4B1/4-ipomeanol Gene Therapy Using the EGR1 Promoter. Anticancer Res. 23, 2723-2728 (2003).
141. Jin, G. H., Jin, S. Z., Liu, Y., Xu, R. M., Yang, J. Z., Pan, X. N., and Liu, S. Z. Therapeutic Effect of Gene-therapy in Combination with Local X-irradiation in a Mouse Malignant Melanoma Model. Biochem. Biophys. Res. Commun. 330, 975-981 (2005).
142. Tanaka, M. and Miyajima, A. Oncostatin M. A Multifunctional Cytokine. Rev. Physiol. Biochem. Pharmacol. 149, 39-52 (2003).
143. Wang, W. D., Chen, Z. T., Li, D. Z., Duan, Y. Z., Wang, Z. X., and Cao, Z. H. Oncostatin M Gene Therapy in Mice Bearing Lung Adenocarcinoma Xenograft Using a Hypoxia/Radiation Dual-sensitive Promoter. Zhonghua Me He He Hu Xi Za Zhi 27, 240-243 (2004).
144. Wang, W. D., Chen, Z. T., Li, D. Z., Duan, Y. Z., Wang, Z. X., and Cao, Z. H. HSV-TK Gene Therapy of Lung Adenocarcinoma Xenografts Using a Hypoxia/radiation Dual-sensitive Promoter. Ai Zheng 23, 788-793 (2004).
145. Ishida, A., Sasaguri, T., Kosaka, C., Nojima, H., and Ogata, J. Induction of the Cyclin-dependent Kinase Inhibitor p21(Sdi1/Cip1/Waf1) by Nitric Oxide-generating Vasodilator in Vascular Smooth Muscle Cells. J. Biol. Chem. 272, 10050-10057 (1997).
146. Steinman, R. A., Hoffman, B., Iro, A., Guillouf, C., Liebermann, D. A., and el-Houseini, M. E. Induction of p21 (WAF-1/CIP1) During Differentiation. Oncogene 9, 3389-3396 (1994).
147. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, A Potential Mediator of p53 Tumor Suppression. Cell 75, 817-825 (1993).
148. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent Pathway. Cancer Res. 54, 3391-3395 (1994).
149. Rimner, A., Wischhusen, J., Naumann, U., Gleichmann, M., Steinbach, J. P., and Weller, M. Identification by Suppression Subtractive Hybridization of p21 as a Radio-inducible Gene in Human Glioma Cells. Anticancer Res. 21, 3505-3508 (2001).
150. Sourvinos, G. and Spandidos, D. A. Decreased BRCA1 Expression Levels May Arrest the Cell Cycle Through Activation of p53 Checkpoint in Human Sporadic Breast Tumors. Biochem. Biophys. Res. Commun. 245, 75-80 (1998).
151. Blundell, R., Kaminski, N., and Harrison, D. Increase in p21 Expression Independent of the p53 Pathway in Bleomycin-induced Lung Fibrosis. Exp. Mol. Pathol. 77, 231-237 (2004).
152. Messmer, U. K., Ankarcrona, M., Nicotera, P., and Brune, B. p53 Expression in Nitric Oxide-induced Apoptosis. FEBS Lett. 355, 23-26 (1994).
153. Yung, H. W., Bal-Price, A. K., Brown, G. C., and Tolkovsky, A. M. Nitric Oxide-induced Cell Death of Cerebrocortical Murine Astrocytes is Mediated Through p53- and Bax-dependent Pathways. J. Neurochem. 89, 812-821 (2004).
154. Li, C. Q., Robles, A. I., Hanigan, C. L., Hofseth, L. J., Trudel, L. J., Harris, C. C., and Wogan, G. N. Apoptotic Signaling Pathways Induced by Nitric Oxide in Human Lymphoblastoid Cells Expressing Wild-type or Mutant p53. Cancer Res. 64, 3022-3029 (2004).
155. Chastel, C., Jiricny, J., and Jaussi, R. Activation of Stress-responsive Promoters by Ionizing Radiation for Deployment in Targeted Gene Therapy. DNA Repair (Amst) 3, 201-215 (2004).
156. Kastan, M. B., Zhan, Q., el-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A Mammalian Cell Cycle Checkpoint Pathway Utilizing p53 and GADD45 is Defective in Ataxia-telangiectasia. Cell 71, 587-597 (1992).
157. Cheng, X. and Iliakis, G. Effect of Ionizing Radiation on the Expression of Chloramphenicol Acetyltransferase Gene Under the Control of Commonly Used Constitutive or Inducible Promoters. Int. J. Radiat. Biol. 67, 261-267 (1995).
158. Beetz, A., Peter, R. U., Oppel, T., Kaffenberger, W., Rupec, R. A., Meyer, M., van Beuningen, D., Kind, P., and Messer, G. NF-kappaB and AP-1 are Responsible for Inducibility of the IL-6 Promoter by Ionizing Radiation in HeLa Cells. Int. J. Radiat. Biol. 76, 1443-1453 (2000).
159. Mairs, R. J., Cunningham, S. H., Boyd, M., and Carlin, S. Applications of Gene Transfer to Targeted Radiotherapy. Curr. Pharm. Des. 6, 1419-1432 (2000).
160. Boyd, M., Spenning, H. S., and Mairs, R. J. Radiation and Gene Therapy: Rays of Hope for the New Millennium? Curr. Gene Ther. 3, 319-339 (2003).
161. Mairs, R. J. and Boyd, M. Targeting Radiotherapy to Cancer by Gene Transfer. J. Biomed. Biotechnol. 2003, 102-109 (2003).
162. Faivre, J., Clerc, J., Gerolami, R., Herve, J., Longuet, M., Liu, B., Roux, J., Moal, F., Perricaudet, M., and Brechot, C. Long-term Radioiodine Retention and Regression of Liver Cancer After Sodium Iodide Symporter Gene Transfer in Wistar Rats. Cancer Res. 64, 8045-8051 (2004).
163. Mitrofanova, E., Unfer, R., Vahanian, N., Daniels, W., Roberson, E., Seregina, T., Seth, P., and Link, C. Jr. Rat Sodium Iodide Symporter for Radioiodide Therapy of Cancer. Clin. Cancer Res. 10, 6969-6976 (2004).
164. Fullerton, N. E., Boyd, M., Mairs, R. J., Keith, W. N., Alderwish, O., Brown, M. M., Livingstone, A., and Kirk, D. Combining a Targeted Radiotherapy and Gene Therapy Approach for Adenocarcinoma of Prostate. Prostate Cancer. Prostatic Dis. 7, 355-363 (2004).
165. Boyd, M., Mairs, R. J., Keith, W. N., Ross, S. C., Welsh, P., Akabani, G., Owens, J., Vaidyanathan, G., Carruthers, R., Dorrens, J., and Zalutsky, M. R. An Efficient Targeted Radiotherapy/Gene Therapy Strategy Utilizing Human Telomerase Promoters and Radioastatine and Harnessing Radiation-mediated Bystander Effects. J. Gene Med. 6, 937-947 (2004).
166. Buchsbaum, D. J. Imaging and Therapy of Tumors Induced to Express Somatostatin Receptor by Gene Transfer Using Radiolabeled Peptides and Single Chain Antibody Constructs. Semin. Nucl. Med. 34, 32-46 (2004).
167. Gulec, S. A., Drouant, G. J., Fuselier, J., Anthony, C. T., Heneghan, J., DelCarpio, J. B., Coy, D. H., Murphy, W. A., and Woltering, E. A. Antitumor and Antiangiogenic Effects of Somatostatin Receptor-targeted In Situ Radiation With (111)In-DTPA-JIC 2DL. J. Surg. Res. 97, 131-137 (2001).
168. Boyd, M., Mairs, S. C., Stevenson, K., Livingstone, A., Clark, A. M., Ross, S. C., and Mairs, R. J. Transfectant Mosaic Spheroids: A New Model for Evaluation of Tumour Cell Killing in Targeted Radiotherapy and Experimental Gene Therapy. J. Gene Med. 4, 567-576 (2002).
169. Carpenter, M., Epperly, M. W., Agarwal, A., Nie, S., Hricisak, L., Niu, Y., and Greenberger, J. S. Inhalation Delivery of Manganese Superoxide Dismutase-plasmid/Liposomes Protects the Murine Lung from Irradiation Damage. Gene Ther. 12, 685-693 (2005).
170. Greenberger, J. S., Epperly, M. W., Gretton, J., Jefferson, M., Nie, S., Bernarding, M., Kagan, V., and Guo, H. L. Radioprotective Gene Therapy. Curr. Gene Ther. 3, 183-195 (2003).
171. Du, N., Feng, K., Luo, C., Li, L., Bai, C., and Pei, X. Radioprotective Effect of FLT3 Ligand Expression Regulated by Egr-1 Regulated Element on Radiation Injury of SCID Mice. Exp. Hematol. 31, 191-196 (2003).
172. Seth, P. Vector-Mediated Cancer Gene Therapy. An Overview. Cancer. Biol. Ther. 4, (2005).
173. Gunther, M., Wagner, E., and Ogris, M. Specific Targets in Tumor Tissue for the Delivery of Therapeutic Genes. Curr. Med. Chem. Anti-Canc Agents 5, 157-171 (2005).
174. Glover, D. J., Lipps, H. J., and Jans, D. A. Towards Safe, Non-viral Therapeutic Gene Expression in Humans. Nat. Rev. Genet. 6, 299-310 (2005).
175. Garcia-Castro, J., Martinez-Palacio, J., Lillo, R., Garcia-Sanchez, F., Alemany, R., Madero, L., Bueren, J. A., and Ramirez, M. Tumor Cells as Cellular Vehicles to Deliver Gene Therapies to Metastatic Tumors. Cancer Gene Ther. 12, 341-349 (2005).
176. Fu, P., Chen, J., Tian, Y., Watkins, T., Cui, X., and Zhao, B. Anti-tumor Effect of Hematopoietic Cells Carrying the Gene of Ribonuclease Inhibitor. Cancer Gene Ther. 12, 268-275 (2005).
177. Lee, C. H., Wu, C. L., and Shiau, A. L. Systemic Administration of Attenuated Salmonella Choleraesuis Carrying Thrombospondin-1 Gene Leads to Tumor-specific Transgene Expression, Delayed Tumor Growth and Prolonged Survival in the Murine Melanoma Model. Cancer Gene Ther. 12, 175-184 (2005).
178. Check, E. Gene-therapy Ttrials to Restart Following Cancer Risk Review. Nature 434, 127 (2005).
179. Manilla, P., Rebello, T., Afable, C., Lu, X., Slepushkin, V., Humeau, L. M., Schonely, K., Ni, Y., Binder, G. K., Levine, B. L., MacGregor, R. R., June, C. H., and Dropulic, B. Regulatory Considerations for Novel Gene Therapy Products: A Review of the Process Leading to the First Clinical Lentiviral Vector. Hum. Gene Ther. 16, 17-25 (2005).
180. Worthington, J., Robson, T., Murray, M., O'Rourke, M., Keilty, G., and Hirst, D. G. Modification of Vascular Tone Using iNOS Under the Control of a Radiation-inducible Promoter. Gene Ther. 7, 1126-1131 (2000).
181. Hillman, G. G., Slos, P., Wang, Y., Wright, J. L., Layer, A., DeMeyer, M., Yudelev, M., Che, M., and Forman, J. D. Tumor Irradiation Followed by Intratumoral Cytokine Gene Therapy for Murine Renal Adenocarcinoma. Cancer Gene Ther. 11, 61-72 (2004).
182. Iwadate, Y., Yamaura, A., Sakiyama, S., Sato, Y., and Tagawa, M. Glioma-specific Cytotoxic T Cells can be Effectively Induced by Subcutaneous Vaccination of Irradiated Wild-type Tumor Cells Without Artificial Cytokine Production. Int. J. Oncol. 23, 483-488 (2003).
183. Bray, D., Yu, S. Z., Koprowski, H., 2nd, Rhee, J., Kumar, S., Pericle, F., Suntharalingam, M., Van Echo, D. A., Li, D., and O'Malley, B. W., Jr. Combination Nonviral Interleukin 2 Gene Therapy and External-beam Radiation Therapy for Head and Neck Cancer. Arch. Otolaryngol. Head. Neck. Surg. 129, 618-622 (2003).
184. Fakhrai, H., Shawler, D. L., Van Beveren, C., Lin, H., Dorigo, O., Solomon, M. J., Gjerset, R. A., Smith, L., Bartholomew, R. M., Boggiano, C. A., Gold, D. P., and Sobol, R. E. Construction and Characterization of Retroviral Vectors for Interleukin-2 Gene Therapy. J. Immunother. 20, 437-448 (1997).
185. Oh, Y. T., Chen, D. W., Dougherty, G. J., and McBride, W. H. Adenoviral Interleukin-3 Gene-radiation Therapy for Prostate Cancer in Mouse Model. Int. J. Radiat. Oncol. Biol. Phys. 59, 579-583 (2004).
186. Chiang, C. S., Hong, J. H., Wu, Y. C., McBride, W. H., and Dougherty, G. J. Combining Radiation Therapy with Interleukin-3 Gene Immunotherapy. Cancer Gene Ther. 7, 1172-1178 (2000).
187. Lohr, F., Hu, K., Haroon, Z., Samulski, T. V., Huang, Q., Beaty, J., Dewhirst, M. W., and Li, C. Y. Combination Treatment of Murine Tumors by Adenovirus-mediated Local B7/IL12 Immunotherapy and Radiotherapy. Mol. Ther. 2, 195-203 (2000).
188. Lohr, F., Hu, K., Huang, Q., Zhang, L., Samulski, T. V., Dewhirst, M. W., and Li, C. Y. Enhancement of Radiotherapy by Hyperthermia-regulated Gene Therapy. Int. J. Radiat. Oncol. Biol. Phys. 48, 1513-1518 (2000).
189. Yang, Y., Liu, S. Z., and Fu, S. B. Anti-tumor Effects of pNEgr-mIL-12 Recombinant Plasmid Induced by X-irradiation and its Mechanisms. Biomed. Environ. Sci. 17, 135-143 (2004).
190. Nishikawa, T., Munshi, A., Story, M. D., Ismail, S., Stevens, C., Chada, S., and Meyn, R. E. Adenoviral-mediated mda-7 Expression Suppresses DNA Repair Capacity and Radiosensitizes Non-small-cell Lung Cancer Cells. Oncogene 23, 7125-7131 (2004).
191. Su, Z. Z., Lebedeva, I. V., Sarkar, D., Gopalkrishnan, R. V., Sauane, M., Sigmon, C., Yacoub, A., Valerie, K., Dent, P., and Fisher, P. B. Melanoma Differentiation Associated Gene-7, mda-7/IL-24, Selectively Induces Growth Suppression, Apoptosis and Radiosensitization in Malignant Gliomas in a p53-independent Manner. Oncogene 22, 1164-1180 (2003).
192. Wang, Y., Xu, M., Che, M., Von Hofe, E., Abbas, A., Kallinteris, N. L., Lu, X., Liss, Z. J., Forman, J. D., and Hillman, G. G. Curative Antitumor Immune Response is Optimal with Tumor Irradiation Followed by Genetic Induction of Major Histocompatibility Complex Class I and Class II Molecules and Suppression of Ii Protein. Hum. Gene Ther. 16, 187-199 (2005).
193. Li, G. C., He, F., Shao, X., Urano, M., Shen, L., Kim, D., Borrelli, M., Leibel, S. A., Gutin, P. H., and Ling, C. C. Adenovirus-mediated Heat-activated Antisense Ku70 Expression Radiosensitizes Tumor Cells In Vitro and In Vivo. Cancer Res. 63, 3268-3274 (2003).
194. Collis, S. J., Tighe, A., Scott, S. D., Roberts, S. A., Hendry, J. H., and Margison, G. P. Ribozyme Minigene-mediated RAD51 Down-regulation Increases Radiosensitivity of Human Prostate Cancer Cells. Nucleic Acids Res. 29, 1534-1538 (2001).
195. Trofimova, I., Dimtchev, A., Jung, M., Rosenthal, D., Smulson, M., Dritschilo, A., and Soldatenkov, V. Gene Therapy for Prostate Cancer by Targeting poly(ADP-ribose) Polymerase. Cancer Res. 62, 6879-6883 (2002).
196. Collis, S. J., Ketner, G. W., Hicks, J. L., Nelson, W. G., Demarzo, A. M., and Deweese, T. L. Expression of the DNA-PK Binding Protein E4-34K Fails to Confer Radiation Sensitivity to Mammalian Cells. Int. J. Radiat. Biol. 79, 53-60 (2003).
197. Collis, S. J., Swartz, M. J., Nelson, W. G., and DeWeese, T. L. Enhanced Radiation and Chemotherapy-mediated Cell Killing of Human Cancer Cells by Small Inhibitory RNA Silencing of DNA Repair Factors. Cancer Res. 63, 1550-1554 (2003).
198. Fan, Z., Chakravarty, P., Alfieri, A., Pandita, T. K., Vikram, B., and Guha, C. Adenovirus-mediated Antisense ATM Gene Transfer Sensitizes Prostate Cancer Cells to Radiation. Cancer Gene Ther. 7, 1307-1314 (2000).
199. Guha, C., Guha, U., Tribius, S., Alfieri, A., Casper, D., Chakravarty, P., Mellado, W., Pandita, T. K., and Vikram, B. Antisense ATM Gene Therapy: A Strategy to Increase the Radiosensitivity of Human Tumors. Gene Ther. 7, 852-858 (2000).
200. Marangoni, E., Le Romancer, M., Foray, N., Muller, C., Douc-Rasy, S., Vaganay, S., Abdulkarim, B., Barrois, M., Calsou, P., Bernier, J., Salles, B., and Bourhis, J. Transfer of Ku86 RNA Antisense Decreases the Radioresistance of Human Fibroblasts. Cancer Gene Ther. 7, 339-346 (2000).
201. Belenkov, A. I., Alakhov, V. Y., Kabanov, A. V., Vinogradov, S. V., Panasci, L. C., Monia, B. P., and Chow, T. Y. Polyethyleneimine Grafted with Pluronic P85 Enhances Ku86 Antisense Delivery and the Ionizing Radiation Treatment Efficacy In Vivo. Gene Ther. 11, 1665-1672 (2004).
202. Yang, D. C., Elliott, R. L., and Head, J. F. Gene Targets of Antisense Therapies in Breast Cancer. Expert Opin. Ther. Targets 6, 375-385 (2002).
203. Luo, X., Andres, M. L., Timiryasova, T. M., Fodor, I., Slater, J. M., and Gridley, D. S. Radiation-enhanced Endostatin Gene Expression and Effects of Combination Treatment. Technol. Cancer. Res. Treat. 4, 193-202 (2005).
204. Shi, W., Teschendorf, C., Muzyczka, N., and Siemann, D. W. Gene Therapy Delivery of Endostatin Enhances the Treatment Efficacy of Radiation. Radiother. Oncol. 66, 1-9 (2003).
205. Yang, W., and Li, X. Y. Anti-tumor Effect of pEgr-interferon-gamma- endostatin Gene-radiotherapy in Mice Bearing Lewis Lung Carcinoma and its Mechanism. Chin. Med. J. (Engl) 118, 296-301 (2005).
206. Kaliberov, S. A., Kaliberova, L. N., and Buchsbaum, D. J. Combined Ionizing Radiation and sKDR Gene Delivery for Treatment of Prostate Carcinomas. Gene Ther. 12, 407-417 (2005).
207. Adachi, Y., Lee, C. T., and Carbone, D. P. Genetic Blockade of the Insulin-like Growth Factor 1 Receptor for Human Malignancy. Novartis Found. Symp. 262, 177-189; discussion 190-192, 265-268 (2004).
208. Min, Y., Adachi, Y., Yamamoto, H., Ito, H., Itoh, F., Lee, C. T., Nadaf, S., Carbone, D. P., and Imai, K. Genetic Blockade of the Insulin-like Growth Factor-I Receptor: A Promising Strategy for Human Pancreatic Cancer. Cancer Res. 63, 6432-6441 (2003).
209. Rochester, M. A., Riedemann, J., Hellawell, G. O., Brewster, S. F., and Macaulay, V. M. Silencing of the IGF1R Gene Enhances Sensitivity to DNA-damaging Agents in Both PTEN Wild-type and Mutant Human Prostate Cancer. Cancer Gene Ther. 12, 90-100 (2005).
210. Lammering, G., Hewit, T. H., Hawkins, W. T., Contessa, J. N., Reardon, D. B., Lin, P. S., Valerie, K., Dent, P., Mikkelsen, R. B., and Schmidt-Ullrich, R. K. Epidermal Growth Factor Receptor as a Genetic Therapy Target for Carcinoma Cell Radiosensitization. J. Natl. Cancer Inst. 93, 921-929 (2001).
211. Lammering, G., Hewit, T. H., Valerie, K., Lin, P. S., Contessa, J. N., and Schmidt-Ullrich, R. K. Anti-erbB Receptor Strategy as a Gene Therapeutic Intervention to Improve Radiotherapy in Malignant Human Tumours. Int. J. Radiat. Biol. 79, 561-568 (2003).
212. Lammering, G., Lin, P. S., Contessa, J. N., Hampton, J. L., Valerie, K., and Schmidt-Ullrich, R. K. Adenovirus-mediated Overexpression of Dominant Negative Epidermal Growth Factor Receptor-CD533 as a Gene Therapeutic Approach Radiosensitizes Human Carcinoma and Malignant Glioma Cells. Int. J. Radiat. Oncol. Biol. Phys. 51, 775-784 (2001).
213. Lammering, G., Valerie, K., Lin, P. S., Mikkelsen, R. B., Contessa, J. N., Feden, J. P., Farnsworth, J., Dent, P., and Schmidt-Ullrich, R. K. Radiosensitization of Malignant Glioma Cells Through Overexpression of Dominant-negative Epidermal Growth Factor Receptor. Clin. Cancer Res. 7, 682-690 (2001).
214. Sak, A., Wurm, R., Elo, B., Grehl, S., Pottgen, C., Stuben, G., Sinn, B., Wolf, G., Budach, V., and Stuschke, M. Increased radiation-induced Apoptosis and Altered Cell Cycle Progression of Human Lung Cancer Cell Lines by Antisense Oligodeoxynucleotides Targeting p53 and p21(WAF1/CIP1). Cancer Gene Ther. 10, 926-934 (2003).
215. Rosser, C. J., Tanaka, M., Pisters, L. L., Tanaka, N., Levy, L. B., Hoover, D. C., Grossman, H. B., McDonnell, T. J., Kuban, D. A., and Meyn, R. E. Adenoviral-mediated PTEN Transgene Expression Sensitizes Bcl-2-expressing Prostate Cancer Cells to Radiation. Cancer Gene Ther. 11, 213-219 (2004).
216. Zhang, R., Wang, H., and Agrawal, S. Novel Antisense Anti-MDM2 mixed-backbone Oligonucleotides: Proof of Principle, In Vitro and In Vivo Activities, and Mechanisms. Curr. Cancer. Drug Targets 5, 43-49 (2005).
217. Gokhale, P. C., Soldatenkov, V., Wang, F. H., Rahman, A., Dritschilo, A., and Kasid, U. Antisense raf Oligodeoxyribonucleotide is Protected by Liposomal Encapsulation and Inhibits Raf-1 Protein Expression In Vitro and In Vivo: Implication for Gene Therapy of Radioresistant Cancer. Gene Ther. 4, 1289-1299 (1997).